G0S2 is an all-trans-retinoic acid target gene

International Journal of Oncology

Volumn 33, Issue 2, 2008, Pages 397-404

  Kitareewan, Sutisak ^a   Blumen, Steven ^a   Sekula, David ^a   Bissonnette, Reid P ^c   Lamph, William W ^c   Cui, Qingping ^b   Gallagher, Robert ^b   Dmitrovsky, Ethan ^a,d  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c Ligand Pharmaceutical   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Differentiation; G0S2; Retinoic acid; Target gene

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; MESSENGER RNA; NITROBLUE TETRAZOLIUM; RETINOIC ACID; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR G0S2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DRUG MECHANISM; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRETINOIN; VITAMIN D RESPONSE ELEMENT;

EID: 48749117181     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_00000021     Document Type: Article

References (29)

1. Warrell RP Jr, Frankel SR, Miller WH Jr, et al: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324: 1385-1393, 1991.
2. Melnick A and Licht JD: Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93: 3167-3215, 1999.
3. Sporn MB, Roberts AB and Goodman DS (eds.): The Retinoids. Vols. 1 and 2. Academic Press, New York, 1984.
4. Raffelsberger W, Dembele D, Neubauer MG, Gottardis MM and Gronemeyer H: Quality indicators increase the reliability of microarray data. Genomics 80: 385-394, 2002.
5. Lee KH, Chang MY, Ahn JI, et al: Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Biochem Biophys Res Commun 296: 1125-1133, 2002.
6. Yang L, Zhao H, Li SW, et al: Gene expression profiling during all-trans-retinoic acid-induced cell differentiation of acute promyelocytic leukemia. J Mol Diagn 5: 212-221, 2003.
7. Freemantle SJ, Spinella MJ and Dmitrovsky E: Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22: 7305-7315, 2003.
8. Mangelsdorf DJ and Evans RM: Retinoid receptors as transcription factors. In: Transcriptional Regulation. McKnight SL and Yamamoto KR (eds.) Cold Spring Harbor Laboratory Press, New York, NY, pp1137-1167, 1992.
9. Cottone E, Orso F, Biglia N, Sismondi P and De Bortoli M: Role of coactivators and corepressors in steroid and nuclear receptor signaling: potential markers of tumor growth and drug sensitivity. Int J Biol Markers 16: 151-166, 2001.
10. Hu X, Li Y and Lazar MA: Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors. Mol Cell Biol 21: 1747-1758, 2001.
11. Zhu J, Gianni M, Kop E, et al: Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor α (RARα) and oncogenic RARα fusion protein. Proc Natl Acad Sci USA 96: 14807-14812, 1999.
12. Kitareewan S, Pitha-Rowe I, Sekula D, et al: UBE1L is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemia. Proc Natl Acad Sci USA 99: 3806-3811, 2002.
13. Nervi C, Ferrara FF, Fanelli M, et al: Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/ RARα fusion protein. Blood 92: 2244-2251, 1998.
14. Tamayo P, Slonim D, Mesirov J, et al: Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 96: 2907-2912, 1999.
15. Forsdyke DR: cDNA cloning of mRNAs which increase rapidly in human lymphocytes cultured with concanavalin-A and cycloheximide. Biochem Biophys Res Commun 129: 619-625, 1985.
16. Siderovski DP, Blum S, Forsdyke RE and Forsdyke DR: A set of human putative lymphocyte G0/G1 switch genes includes genes homologous to rodent cytokine and zinc finger protein-encoding gene. DNA Cell Biol 9: 579-587, 1990.
17. 1 switch gene 2 is a novel PPAR target gene. Biochem J 392: 313-324, 2005.
18. 1 switch gene containing a CpG-rich island encodes a small basic protein with the potential to be phosphorylated. DNA Cell Biol 10: 581-591, 1991.
19. 2) in cultured human blood mononuclear cells. DNA Cell Biol 16: 1449-1458, 1997.
20. Pitha-Rowe I, Petty WJ, Kitareewan S and Dmitrovsky E: Retinoid target genes in acute promyelocytic leukemia. Leukemia 17: 1723-1730, 2003.
21. Nason-Burchenal K, Maerz W, Albanell J, Allopenna J, Martin P, Moore MAS and Dmitrovsky E: Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Differentiation 61: 321-331, 1997.
22. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F and Berger R: NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77: 1080-1086, 1991.
23. Henikoff S: Unidirectional digestion with exonuclease III in DNA sequence analysis. Meth Enzymol 155: 156-165, 1987.
24. Kato JY, Matsuoka M, Strom DK and Sherr CJ: Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol Cell Biol 14: 2713-2721, 1994.
25. The QIAexpressionist: A handbook for high-level expression and purification of 6xHis-tagged protein. 5th edition. Qiagen, Valencia, CA, 2001.
26. Lallemand-Breitenbach V, Guillemin MC, Janin, A, et al: Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. J Exp Med 189: 1043-1052, 1999.
27. Zhou DC, Hallam SJ, Lee SJ, Klein RS, Wiernik PH, Tallman MS and Gallagher RE: Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans-retinoic acid in acute promyelocytic leukemia cells. Cancer Res 58: 5770-5776, 1998.
28. Quandt K, Frech K, Karas H, Wingender E and Werner T: MatInd and MatInspector-New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acid Res 23: 4878-4884, 1995.
29. Nason-Burchenal K, Allopenna J, Begue A, Stehelin D, Dmitrovsky E and Martin P: Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells. Blood 92: 1758-1767, 1998.